HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
J Mendelsohn Selected Research
J Mendelsohn Research Topics
Disease
18
Neoplasms (Cancer)
01/2019 - 01/2000
6
Colonic Neoplasms (Colon Cancer)
07/2001 - 05/2000
5
Breast Neoplasms (Breast Cancer)
03/2001 - 01/2000
4
Carcinoma (Carcinomatosis)
07/2001 - 11/2000
2
Head and Neck Neoplasms (Head and Neck Cancer)
05/2001 - 03/2001
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2001
1
Squamous Cell Carcinoma of Head and Neck
05/2001
1
Retinoblastoma (Glioblastoma, Retinal)
04/2001
1
Pancreatic Neoplasms (Pancreatic Cancer)
03/2001
1
Neoplasm Metastasis (Metastasis)
03/2001
1
Ovarian Neoplasms (Ovarian Cancer)
11/2000
1
Hemorrhage
02/2000
1
Necrosis
02/2000
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2000
1
Thrombosis (Thrombus)
02/2000
1
Disease Progression
02/2000
1
Adenocarcinoma
01/2000
Drug/Important Bio-Agent (IBA)
13
ErbB Receptors (EGF Receptor)
IBA
09/2001 - 02/2000
7
Cetuximab (Erbitux)
FDA Link
05/2001 - 02/2000
7
Epidermal Growth Factor (EGF)
IBA
04/2001 - 01/2000
6
Monoclonal Antibodies
IBA
03/2001 - 02/2000
5
Transforming Growth Factor alpha (TGF-alpha)
IBA
09/2001 - 07/2000
4
Paclitaxel (Taxol)
FDA Link
Generic
07/2001 - 01/2000
4
Cisplatin (Platino)
FDA Link
Generic
07/2001 - 02/2000
3
Antisense Oligonucleotides
IBA
07/2001 - 09/2000
3
Messenger RNA (mRNA)
IBA
07/2001 - 12/2000
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2001 - 09/2000
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
02/2001 - 01/2000
2
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 01/2016
2
Agar
IBA
07/2001 - 11/2000
2
Proteins (Proteins, Gene)
FDA Link
03/2001 - 12/2000
2
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
03/2001 - 09/2000
2
Oligonucleotides
IBA
11/2000 - 09/2000
1
Mitogens
IBA
09/2001
1
Phosphotransferases (Kinase)
IBA
09/2001
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
09/2001
1
Antineoplastic Agents (Antineoplastics)
IBA
07/2001
1
Biological Products
IBA
07/2001
1
Topotecan (Hycamtin)
FDA Link
Generic
07/2001
1
Doxorubicin (Adriamycin)
FDA Link
Generic
07/2001
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
05/2001
1
Cyclins
IBA
04/2001
1
Retinoblastoma Protein
IBA
04/2001
1
Heterogeneous-Nuclear Ribonucleoprotein K
IBA
03/2001
1
Irinotecan (Camptosar)
FDA Link
Generic
03/2001
1
Gemcitabine
FDA Link
03/2001
1
Peptide Elongation Factor 1 (EF-1)
IBA
02/2001
1
Histones (Histone)
IBA
02/2001
1
Trastuzumab (Herceptin)
FDA Link
12/2000
1
Antibodies
IBA
12/2000
1
Tyrosine Kinase Inhibitors
IBA
12/2000
1
histidine-rich proteins
IBA
12/2000
1
CD34 Antigens (CD34 Antigen)
IBA
12/2000
1
p21-Activated Kinases
IBA
12/2000
1
Cyclic AMP-Dependent Protein Kinase Type I
IBA
11/2000
1
Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
IBA
11/2000
1
Cytostatic Agents
IBA
09/2000
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
07/2000
1
Pharmaceutical Preparations
IBA
07/2000
1
Caspases
IBA
06/2000
1
JNK Mitogen-Activated Protein Kinases
IBA
06/2000
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
05/2000
1
Ecdysone
IBA
05/2000
1
Cytotoxins (Cytolysins)
IBA
02/2000
1
Growth Factor Receptors
IBA
02/2000
1
A-factor (Streptomyces)
IBA
02/2000
Therapy/Procedure
7
Therapeutics
08/2015 - 01/2000
5
Radiotherapy
03/2001 - 01/2000
3
Drug Therapy (Chemotherapy)
03/2001 - 01/2000
2
Aftercare (After-Treatment)
07/2001 - 09/2000
1
Precision Medicine
08/2015
1
Withholding Treatment
11/2000
1
Injections
02/2000